Enlivex Ltd. has announced an Extraordinary General Meeting of Shareholders scheduled for December 4, 2026. This meeting is significant as it will allow shareholders to vote on a proposal to increase the company's authorized share capital. The decision reflects a strategic move that could impact the company's growth and operational flexibility.

Enlivex Ltd., based in Israel, operates in the finance services sector, focusing on innovative solutions in the industry. The company is listed on the Nasdaq under the ticker symbol ENLV. This filing is part of a series of recent communications, including a proxy statement and notice related to the upcoming meeting.

According to the filing dated November 17, 2026, the Extraordinary General Meeting will take place at 10:00 a.m. Israel time at the company's offices in Nes Ziona, Israel. The notice and proxy statement, which detail the agenda and voting procedures, have been attached to the filing.

The proposal at the meeting aims to amend the company's Articles of Association to facilitate an increase in authorized share capital. The Board of Directors has recommended that shareholders vote "FOR" this proposal. Shareholders of record as of November 20, 2026, are entitled to vote at the meeting.

This decision could affect various stakeholders, including shareholders and potential investors, as it may signal the company's readiness to pursue new opportunities or enhance its financial structure. The finance services industry may also observe similar trends as companies navigate evolving market conditions.

Looking ahead, the company will continue to engage with its shareholders as it prepares for the meeting. The filing does not specify any further steps beyond the meeting, but it underscores the importance of shareholder participation in shaping the company's future.